Chemoinformaics analysis of 3,6-di-O-galloyl-(alpha/beta)-4C1-glucopyranose
Molecular Weight | 484.366 | nRot | 9 |
Heavy Atom Molecular Weight | 464.206 | nRig | 15 |
Exact Molecular Weight | 484.085 | nRing | 2 |
Solubility: LogS | -1.42 | nHRing | 0 |
Solubility: LogP | -0.102 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 14 | No. of Arom Bond | 12 |
nHA | 14 | APOL | 57.9639 |
nHD | 9 | BPOL | 26.1401 |
QED | 0.146 |
Synth | 3.949 |
Natural Product Likeliness | 0.834 |
NR-PPAR-gamma | 0.069 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.01 |
Pgp-sub | 0.445 |
HIA | 0.877 |
CACO-2 | -6.671 |
MDCK | 0.00000982 |
BBB | 0.078 |
PPB | 0.848183 |
VDSS | 0.527 |
FU | 0.136503 |
CYP1A2-inh | 0.247 |
CYP1A2-sub | 0.012 |
CYP2c19-inh | 0.013 |
CYP2c19-sub | 0.031 |
CYP2c9-inh | 0.155 |
CYP2c9-sub | 0.083 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.114 |
CYP3a4-inh | 0.079 |
CYP3a4-sub | 0.008 |
CL | 11.257 |
T12 | 0.985 |
hERG | 0.265 |
Ames | 0.063 |
ROA | 0.001 |
SkinSen | 0.916 |
Carcinogencity | 0.005 |
EI | 0.901 |
Respiratory | 0.015 |
NR-Aromatase | 0.156 |
Antiviral | Yes |
Prediction | 0.513514 |